New obesity drug, Meridia

    Knoll is now shipping their new obesity drug, Meridia.

    Meridia (sibutramine) suppresses appetite by inhibiting the reuptake of norepinephrine...serotonin...and to a lesser extent, dopamine.

    This helps patients stick to a low calorie diet...leading to about a 5% to 10% weight loss.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote